Evidence map›Paper›PMID 29329209›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates.

Rossella Dorati, Antonella DeTrizio, Melissa Spalla, Roberta Migliavacca, Laura Pagani, Silvia Pisani, Enrica Chiesa, Bice Conti, Tiziana Modena, Ida Genta

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rossella DoratiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. rossella.dorati@unipv.it.
Antonella DeTrizioDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. antonella.detrizio01@universitadipavia.it.
Melissa SpallaDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, Unit of Microbiology and Clinical Microbiology, University of Pavia, 27100 Pavia, Italy. melissa.spalla@unipv.it.
Roberta MigliavaccaDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, Unit of Microbiology and Clinical Microbiology, University of Pavia, 27100 Pavia, Italy. roberta.migliavacca@unipv.it.
Laura PaganiDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, Unit of Microbiology and Clinical Microbiology, University of Pavia, 27100 Pavia, Italy. laura.pagani@unipv.it.
Silvia PisaniDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. silvia.pisani01@universitadipavia.it.
Enrica ChiesaDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. enrica.chiesa01@gmail.com.
Bice ContiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. bice.conti@unipv.it.ORCID 0000-0002-0034-2815
Tiziana ModenaDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. tiziana.modena@unipv.it.
Ida GentaDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. Ida.genta@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is a promising approach both for restoring or enhancing activity of old and conventional antimicrobial agents and for treating intracellular infections by providing intracellular targeting and sustained release of drug inside infected cells. The present paper introduces a formulation study of gentamicin loaded biodegradable nanoparticles (Nps). Solid-oil-in water technique was studied for gentamicin sulfate nanoencapsulation using uncapped Polylactide-co-glycolide (PLGA-H) and Polylactide-co-glycolide-co-Polyethylenglycol (PLGA-PEG) blends. Screening design was applied to optimize: drug payload, Nps size and size distribution, stability and resuspendability after freeze-drying. PLGA-PEG concentration resulted most significant factor influencing particles size and drug content (DC): 8

Indexed as

antimicrobial effectgentamicin sulfatenanoparticlespolyethylenglycolpolylactide-co-glycolide

Identifiers

PMID29329209
PMCPMC5791124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.